Ready for Qwo®?

Bring a different treatment for cellulite into your practice

Woman standing with arms crossed.

Want to know more about QWO and how to become a certified provider?

Congrats! Your form submitted successfully, thank you. You’re now one step closer to becoming a QWO provider.

Email Subscription Form

Please check the fields below.

Fill out the form and choose your preferences:

All fields are required

Endo Aesthetics LLC understands that your privacy is important. By providing your information and clicking the submit button, you are giving Endo Aesthetics and other parties working with us permission to communicate with you. We will send you up-to-date information, as well as future Endo Aesthetics information that may be of interest. We will not sell the information you provide to any party for its marketing use. To view our privacy policy, please visit www.endo.com/privacy-legal.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

There was a problem with your request. Please try again later.

Indication

Qwo® is indicated for the treatment of moderate to severe cellulite in the buttocks of adult women.

Important Safety Information for QWO

Contraindications

QWO is contraindicated in patients with a history of hypersensitivity to collagenase or to any of the excipients or the presence of infection at the injection sites.

Warnings and Precautions

Hypersensitivity Reactions

Serious hypersensitivity reactions including anaphylaxis have been reported with the use of collagenase clostridium histolyticum. If such a reaction occurs, further injection of QWO should be discontinued and appropriate medical therapy immediately instituted. Advise patients to seek immediate medical attention if they experience any symptoms of serious hypersensitivity reactions.

Injection Site Bruising

In clinical trials, 84% of subjects treated with QWO experienced injection site bruising. Subjects with coagulation disorders or using anticoagulant or antiplatelet medications (except those taking ≤150 mg aspirin daily) were excluded from participating in Trials 1 and 2.

QWO should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet (except those taking ≤150 mg aspirin daily) or anticoagulant therapy.

Substitution of Collagenase Products

QWO must not be substituted with other injectable collagenase products.

QWO is not intended for the treatment of Peyronie’s Disease or Dupuytren’s Contracture.

Adverse Reactions

In clinical trials, the most commonly reported adverse reactions in patients treated with QWO with an incidence ≥ 10% were at the injection site: bruising, pain, nodule and pruritus.

View Full Prescribing Information for QWO.